Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01059929 · ClinicalTrials.gov registry record · Phase 4
Dexmedetomidine Versus Propofol in the Medical Intensive Care Unit (MICU)
A Phase 4 study, sponsored by University of Chicago.
- Terminated
- Registry status
- Phase 4
- Development phase
- 41
- Enrollment target
NCT01059929 is a Phase 4 study that was terminated before completion, run by University of Chicago. The registered enrollment target is 41 participants.
The verdict
NCT01059929, a Phase 4 study, was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 41 participants
- Enrollment target
Study Summary
This is a randomized controlled trial to compare propofol to dexmedetomidine for prolonged sedation (\> 24 hours) in critically ill patients who require mechanical ventilation.
Interventions
- DRUG Midazolam
- DRUG Dexmedetomidine
- DRUG Propofol
- DRUG Fentanyl
- BEHAVIORAL Physical and Occupational Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2009-09 |
| Est. Completion | 2015-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01059929
The ClinicalTrials.gov registry entry for NCT01059929 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Midazolam is the first listed.
NCT01059929 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01059929 about?
NCT01059929 is a clinical study titled "Dexmedetomidine Versus Propofol in the Medical Intensive Care Unit (MICU)". This is a randomized controlled trial to compare propofol to dexmedetomidine for prolonged sedation (\> 24 hours) in critically ill patients who require mechanical ventilation.
What is the current status of trial NCT01059929?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 41 participants. The study started on 2009-09. Estimated completion is 2015-09.
What interventions are being tested in trial NCT01059929?
The interventions under investigation include: Midazolam (DRUG), Dexmedetomidine (DRUG), Propofol (DRUG), Fentanyl (DRUG), Physical and Occupational Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01059929?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.